BibTex RIS Kaynak Göster

Rhabdomyolysis Related Statine and Fibrate Combination Theraphy: A Single Case

Yıl 2013, Cilt: 2 Sayı: 2, 171 - 172, 01.05.2013

Ahsen Zeyrek İşçi Gülali Aktaş Sevim Karaçay Haluk Şavlı

https://doi.org/10.5505/abantmedj.2013.38039

Kaynakça

  • A. Grundy SM. Can statins cause chronic low-grade myopathy? Ann Intern Med 2002; 137:617.
  • Sathasivam S, Lecky B Statin induced myo- pathy.BMJ. 2008 Nov 6;337:2286
  • Sathasivam S. Statin induced myotoxicity. Eur J Intern Med. 2012 Jun;23(4):317-24
  • Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; Ameri- can College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Sta- tins.Stroke. 2002 Sep;33(9):2337-41
  • Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study Cardiovasc Drugs Ther. 2005 Dec;19(6):403-14
  • Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P Meta- analysis of drug-induced adverse events associated with intensive-dose statin the- rapy Clin Ther. 2007 Feb;29(2):253-60
  • Antons KA, Williams CD, Baker SK, Phillips PS.Clinical perspectives of statin-induced rhabdomyolysis Am J Med. 2006 May;119(5):400-9
  • Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A. Incidence of hospi- talized rhabdomyolysis with statin and fib- rate use in an insured US population. Ann Pharmacother. 2011 Oct;45(10):1230-9.
  • Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstİl K, Bryniarski L, Császár A, Vanderbist F. Safety of a fixed- dose te/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials. Clin Drug Investig. 2012 Apr 1;32(4):281-91
  • Davidson MH, Armani A, McKenney JM, Ja- cobson TA Safety considerations with fibra- te therapy Am J Cardiol. 2007 Mar 19;99(6A):3C-18C
  • Baer AN, Wortmann RL Myotoxicity associ- ated with lipid-lowering drugs Curr Opin Rheumatol. 2007 Jan;19(1):67-73
  • Wu J, Song Y, Li H, Chen J. Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. Eur Dec;65(12):1169-74 2009

Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle

Yıl 2013, Cilt: 2 Sayı: 2, 171 - 172, 01.05.2013

Ahsen Zeyrek İşçi Gülali Aktaş Sevim Karaçay Haluk Şavlı

https://doi.org/10.5505/abantmedj.2013.38039

Kaynakça

  • A. Grundy SM. Can statins cause chronic low-grade myopathy? Ann Intern Med 2002; 137:617.
  • Sathasivam S, Lecky B Statin induced myo- pathy.BMJ. 2008 Nov 6;337:2286
  • Sathasivam S. Statin induced myotoxicity. Eur J Intern Med. 2012 Jun;23(4):317-24
  • Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy SM, Cleeman JI, Lenfant C; Ameri- can College of Cardiology; American Heart Association; National Heart, Lung and Blood Institute. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Sta- tins.Stroke. 2002 Sep;33(9):2337-41
  • Bruckert E, Hayem G, Dejager S, Yau C, Bégaud B Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study Cardiovasc Drugs Ther. 2005 Dec;19(6):403-14
  • Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P Meta- analysis of drug-induced adverse events associated with intensive-dose statin the- rapy Clin Ther. 2007 Feb;29(2):253-60
  • Antons KA, Williams CD, Baker SK, Phillips PS.Clinical perspectives of statin-induced rhabdomyolysis Am J Med. 2006 May;119(5):400-9
  • Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A. Incidence of hospi- talized rhabdomyolysis with statin and fib- rate use in an insured US population. Ann Pharmacother. 2011 Oct;45(10):1230-9.
  • Farnier M, Marcereuil D, De Niet S, Ducobu J, Steinmetz A, Retterstİl K, Bryniarski L, Császár A, Vanderbist F. Safety of a fixed- dose te/pravastatin 160 mg/40 mg in patients with mixed hyperlipidaemia: a pooled analysis from a database of clinical trials. Clin Drug Investig. 2012 Apr 1;32(4):281-91
  • Davidson MH, Armani A, McKenney JM, Ja- cobson TA Safety considerations with fibra- te therapy Am J Cardiol. 2007 Mar 19;99(6A):3C-18C
  • Baer AN, Wortmann RL Myotoxicity associ- ated with lipid-lowering drugs Curr Opin Rheumatol. 2007 Jan;19(1):67-73
  • Wu J, Song Y, Li H, Chen J. Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report. Eur Dec;65(12):1169-74 2009
Toplam 12 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Editöre Mektup
Yazarlar

Ahsen Zeyrek İşçi Bu kişi benim

Gülali Aktaş Bu kişi benim

Sevim Karaçay Bu kişi benim

Haluk Şavlı Bu kişi benim

Yayımlanma Tarihi 1 Mayıs 2013
Yayımlandığı Sayı Yıl 2013 Cilt: 2 Sayı: 2

Kaynak Göster

APA İşçi, A. Z., Aktaş, G., Karaçay, S., Şavlı, H. (2013). Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle. Abant Medical Journal, 2(2), 171-172. https://doi.org/10.5505/abantmedj.2013.38039
AMA İşçi AZ, Aktaş G, Karaçay S, Şavlı H. Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle. Abant Med J. Mayıs 2013;2(2):171-172. doi:10.5505/abantmedj.2013.38039
Chicago İşçi, Ahsen Zeyrek, Gülali Aktaş, Sevim Karaçay, ve Haluk Şavlı. “Statin Ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle”. Abant Medical Journal 2, sy. 2 (Mayıs 2013): 171-72. https://doi.org/10.5505/abantmedj.2013.38039.
EndNote İşçi AZ, Aktaş G, Karaçay S, Şavlı H (01 Mayıs 2013) Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle. Abant Medical Journal 2 2 171–172.
IEEE A. Z. İşçi, G. Aktaş, S. Karaçay, ve H. Şavlı, “Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle”, Abant Med J, c. 2, sy. 2, ss. 171–172, 2013, doi: 10.5505/abantmedj.2013.38039.
ISNAD İşçi, Ahsen Zeyrek vd. “Statin Ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle”. Abant Medical Journal 2/2 (Mayıs 2013), 171-172. https://doi.org/10.5505/abantmedj.2013.38039.
JAMA İşçi AZ, Aktaş G, Karaçay S, Şavlı H. Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle. Abant Med J. 2013;2:171–172.
MLA İşçi, Ahsen Zeyrek vd. “Statin Ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle”. Abant Medical Journal, c. 2, sy. 2, 2013, ss. 171-2, doi:10.5505/abantmedj.2013.38039.
Vancouver İşçi AZ, Aktaş G, Karaçay S, Şavlı H. Statin ve Fenofibrat Birlikte Kullanımına Bağlı Rabdomyoliz: Bir Olgu Nedeniyle. Abant Med J. 2013;2(2):171-2.